Prologue

The medical device industry has entered a critical window for accelerated commercialization of innovative achievements. In response to the Spring Rain Action launched by the National Medical Products Administration (NMPA) to boost translation of clinical medical device innovations, the Medical Device Frontier Technology & Commercialization Summit themed Hundreds of Islands Gather Innovation, Medical Devices Forge Medical Path was successfully held in Conference Area 2, Hall 12.2 of the Canton Fair Complex on August 22, 2026.

Guided by the Guangdong Provincial Association for Science and Technology and Guangdong Provincial Foundation for Revitalizing Science and Technology, the Bureau of Science, Technology, Industry and Information Technology of Yuexiu District, Guangzhou; hosted by Guangdong Provincial Research Institute for Innovative Cerebrovascular Therapeutic Devices and Guangzhou Shangjun Investment Consulting Co., Ltd.; co-hosted by Guangdong Biomedical Innovation & Commercialization Center and China-Europe Science and Technology Investment Promotion Association; co-organized by Guangdong Association for High-quality Development of Biomedical Industry and Guangzhou International Science and Technology Exchange Association; and supported by Beijing Yulisheng Intellectual Property Agency Co., Ltd.

Opening Session

The summit was hosted by He Xucong from Guangzhou Shangjun Investment Consulting Co., Ltd., who extended sincere welcome to all guests on behalf of all organizers and co-organizers.

Policy Sharing: Forging a New Hub of Life Sciences & Healthcare in the Greater Bay Area

Feng Xiaojing, Director of Comprehensive Planning Department, Investment Promotion Service Center, Yuexiu District Commerce Bureau, delivered a keynote speech titled Guangzhou Health City – A New Highland of Life Science & Healthcare Industry in the Guangdong-Hong Kong-Macao Greater Bay Area. Officially incorporated into Guangzhou’s 15th Five-Year Plan, Guangzhou Health City is located in Yuexiu District with a layout of "One Core, Two Featured Zones":

• The core zone focuses on biomedical technology transfer and clinical services;

• The Around Luhu Lake area builds an integrated medical-elderly care-aesthetic wellness ecosystem;

• The riverside zone integrates Lingnan traditional Chinese medicine and healthcare finance industries.

Nearly 20 hospital upgrading projects with total investment exceeding RMB 7 billion have been advanced in the zone, home to 20 key industrial service platforms. It is emerging as a core carrier for high-quality growth of the biomedical industry across the Greater Bay Area.

Talent Alliance: 11 Cross-disciplinary Experts Appointed as Advisors

Talent is the foundation of industrial innovation and the core driver for high-quality development of life sciences. Gathering top industry elites and multidisciplinary expertise to empower industrial iteration is critical for breakthroughs in regional biomedical and medical device sectors. A certificate awarding ceremony for expert advisors of the Talent Alliance for Life Science Industry Innovation Zone of the Greater Bay Area was held. Xu Xiaohui, Deputy Director of the Bureau of Science, Technology, Industry and Information Technology of Yuexiu District, Guangzhou, presented appointment letters to 11 newly appointed experts covering clinical practice, scientific research, industrial development and intellectual property services:

1. Professor Ding Yue, Director, Department of Orthopedics & Medical-Engineering Integration Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University

2. Professor Xue Ling, Director, Cardiac Care Unit (CCU), Guangdong Provincial People’s Hospital

3. Professor Yu Guangchuang, Director, Department of Bioinformatics, School of Basic Medical Sciences, Southern Medical University

4. Dr. Li Dongshi, Associate Chief Physician, Center for Neurology, Guangdong Second Provincial General Hospital

5. Sun Jingsheng, Chairman, Beijing Zhongguancun Shuimu Medical Technology Co., Ltd.

6. Chen Jingdong, Deputy Director, Guangdong Science and Technology Innovation Training Center

7. Jiang Feizhou, Director, Scientific Research Department, Guangdong Provincial People’s Hospital

8. Associate Professor He Feiying, Deputy Dean, Entrepreneurship School & Master Supervisor, School of Health Management, Southern Medical University

9. Wang Yingfeng, Director, Research Commercialization Office, Southern Medical University

10. Researcher Ou Caiwen, Southern Medical University

11. Meng Xiangbin, General Manager, Beijing Yulisheng Intellectual Property Agency Co., Ltd.

This cross-disciplinary advisory team spanning clinical, research and industrial sectors will provide direct support to the innovation zone in technology evaluation, achievement transformation and talent cultivation.

Certificate Issuance Ceremony for Scientific & Technological Achievements Evaluation by Hong Kong Standards Association

Scientific achievement evaluation acts as a vital bridge translating lab innovations into industrial applications, offering authoritative third-party value endorsement for research outcomes. At the ceremony, Zhu Zhilan, Deputy Dean of Guangdong Provincial Research Institute for Innovative Cerebrovascular Therapeutic Devices, issued scientific achievement evaluation certificates to representatives from two enterprises: Guangzhou Anhao Pharmaceutical Technology Co., Ltd. and Yimiji Technology (Guangzhou) Co., Ltd. These certificates serve as key supporting documents for subsequent industrial matching and project landing.

Ecosystem Development: From Laboratory to Marketplace

Keynote: Linkage, Integration, Commercialization – Building a Full-chain Service Ecosystem for Medical Device Innovation

Speaker: Xie Xixin, Secretary-General, Guangdong Provincial Research Institute for Innovative Cerebrovascular Therapeutic Devices

Secretary-General Xie shared insights on medical device industrial development, illustrating how the institute connects evaluation, patent incubation, industrial incubation, capital investment and project landing into an integrated pipeline, unblocking the full path from laboratory R&D to finished products and market launch. She emphasized that constructing a full-chain service ecosystem for medical device innovation is key to industrial upgrading and enhancing core competitiveness. The institute fully practices the philosophy of Linkage, Integration, Commercialization:

• Closely connect universities, research institutes and enterprises to pool innovative resources;

• Deeply integrate technology, talent and capital to break barriers restricting medical device innovation;

• Accelerate the commercialization of scientific achievements to deliver innovative products to market, fuel industrial momentum and strengthen competitiveness for high-quality industrial growth.

Unveiling Ceremony of the Research Commercialization Center, Guangdong Provincial Cerebrovascular Medical Device Research Institute

The Research Commercialization Center under Guangdong Provincial Research Institute for Innovative Cerebrovascular Therapeutic Devices was officially inaugurated at the summit, alongside an expert advisor appointment ceremony. Four specialists were appointed as center advisors: Professor He Feiying (School of Health Management, Southern Medical University), Director Jiang Feizhou (Scientific Research Department, Guangdong Provincial People’s Hospital), Researcher Ou Caiwen (Southern Medical University) and Director Wang Yingfeng (Research Commercialization Office, Southern Medical University).

The appointed advisors boast profound academic backgrounds and rich experience in clinical practice and industrial translation, covering scientific research administration of provincial Grade A tertiary hospitals, university technology transfer and clinical research. Leveraging their think tank capacity, they will provide professional guidance on center planning, project assessment, industry-university-research collaboration and talent cultivation, while supporting the center to integrate resources from hospitals, universities and enterprises to speed up commercialization of medical device innovations.

Led by Director Ni Chunxu, the Research Commercialization Center coordinates multi-party resources from universities, hospitals and enterprises to oversee daily operations, with Deputy Director Zhao Yuxuan in charge of specific implementation. As a hub facilitating industry-university-research cooperation for medical devices, the center focuses on core businesses:

1. Jointly develop research topics with universities and hospitals to align academic research with industrial demands;

2. Deliver precise technology matching to translate lab findings into practical clinical applications;

3. Discover and nurture early-stage innovative projects with commercial potential.

These measures fully unblock the transformation pipeline: Laboratory → Center → Enterprise, supplying innovative products and talents for the Greater Bay Area medical device industry. At the unveiling ceremony, Director Ni shared the center’s practices in industry-education integration and coordinated innovation, and discussed further deepening cooperation with attending representatives from universities, research institutes and enterprises to bring medical technologies to market faster.

Keynote: Credible & Traceable Agent Workbench for Life Science Research

Speaker: Professor Yu Guangchuang, Director, Department of Bioinformatics, School of Basic Medical Sciences, Southern Medical University

Professor Yu addressed core data pain points in life science research such as scattered records and incomplete evidence trails, introducing technical solutions to ensure traceable data sources and full-process auditability. The unified platform enables precise analysis and standardized data management, reducing errors from data migration and improving research reliability and efficiency.

Keynote: Turning Exhibits into Commodities, Innovations into Market – Pathways for Medical Device Marketization

Speaker: Yang Zhongming, Director, Medical Innovation Integration Center

Director Yang focused on marketization challenges for medical devices, analyzing bottlenecks blocking innovative prototypes from commercialization: long clinical recognition cycles, complicated hospital access approval procedures, insufficient market trust in high-end domestic devices, and numerous promising lab prototypes failing to reach clinical application.

He noted Yuexiu District hosts over 1,000 biomedical market entities with abundant distributors and agency channels, laying solid industrial ground for device commercialization. The core solution lies in clinical-value-driven R&D with market thinking embedded at early stages, leveraging mature regional distribution networks to build a collaborative platform for medical device distributors, coordinate tiered channel layout and academic promotion, activate local circulation resources and streamline the entire process from prototype to market-ready commodity.

Keynote: R&D of Novel Portable AI Ultrasonic Bone Densitometer

Speaker: Professor Ding Yue, Director, Department of Orthopedics & Medical-Engineering Integration Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Professor Ding outlined R&D background and technical principles, comparing limitations of traditional equipment and highlighting core innovations in portability and intelligence. Conventional large-scale bone densitometers require fixed dedicated rooms with high operational thresholds, while this lightweight device enables bedside and community screening, fully meeting grassroots population screening and rapid bedside assessment demands.

Keynote: Independently Controlled Anti-phase Synchronized Respiratory Assistance Method and Equipment

Speaker: Dr. Wang Rui, Guangdong Provincial People’s Hospital

From Professor Xue Ling’s research team, Dr. Wang elaborated R&D concepts and working principles of the device featuring independent control and anti-phase synchronization for respiratory support, introduced its superior synchronization and stability performance, and shared clinical outcomes and prospects, pioneering new technical pathways for respiratory disease diagnosis and treatment.

Keynote: Innovation Road of Domestic Flow Diverter Devices

Speaker: Dr. Li Dongshi, Associate Chief Physician, Center for Neurology, Guangdong Second Provincial General Hospital

Dr. Li reviewed the evolution of domestic flow diverters from catch-up to parallel innovation, breaking down key technical breakthroughs in materials, structure and manufacturing processes, while addressing real challenges including lengthy verification cycles and complex clinical access procedures. He illustrated how sustained independent innovation upgraded product performance and quality, demonstrating the competitiveness and growth potential of domestic high-end medical devices.

Keynote: CXO Technical Service Platform – Practices & Reflections on Boosting Efficient Medical Device Commercialization

Speaker: Sun Jingsheng, Chairman, Beijing Zhongguancun Shuimu Medical Technology Co., Ltd.

Chairman Sun shared industrial case studies illustrating how the platform connects full R&D, registration and production workflows. Small and medium innovative teams gain end-to-end professional support from project initiation to mass production without building complete in-house industrial chains. Resource integration and capacity sharing improve transformation efficiency, cut corporate costs and project risks, maximizing utilization of innovative resources.

Keynote: Positioning of Guangdong Biomedical Innovation & Commercialization Center and Industrial Translation Practices

Speaker: Liao Weiliang, Chairman, Guangdong Biomedical Innovation & Commercialization Center

Chairman Liao clarified the center’s mission as a hub for biomedical technology transfer. Combining real industrial practices, he demonstrated how the center converts early-stage innovations into bankable industrial projects via project matching, startup incubation and industrial cultivation, citing replicable successful closed-loop cases as practical benchmarks for the industry.

Keynote: Medical-Engineering Translation & Clinical Application of Precision Nutrition for Accelerated Wound Healing

Speaker: Yang Kewei, Dean, Guangdong Yirun Health Life Science Research Institute

Dean Yang shared institutional practices on precision nutrition to accelerate wound repair and its cross-disciplinary translation to clinical use. Starting with biological mechanisms of tissue regeneration supported by targeted nutrition, he showcased product R&D and real-world clinical deployment, highlighting how medical-engineering integration removes commercialization barriers and delivers a viable new solution for wound care.

Exhibition Interaction: Precise Industry-Demand Matching

The summit yielded fruitful outcomes empowering high-quality industrial development

The summit built an integrated platform for policy exchange, technology sharing, achievement matching and resource linkage, facilitating convergence of policy, technology, talent and capital to accelerate commercialization of innovations. Uniting resources from the Greater Bay Area and nationwide, it resolved obstacles to medical-engineering translation and cross-party collaboration, supporting regional industrial upgrading.

After keynote sessions, guests toured the innovation exhibition zone for close-up experience of cutting-edge products. Direct one-on-one negotiations between supply and demand parties turned multiple memorandums into actionable follow-up plans, laying solid ground for technical cooperation and project landing with tangible matching results.

Unite Forces for Innovation, Jointly Blueprint New Industrial Growth

The Hundreds of Islands Gather Innovation, Medical Devices Forge Medical Path Summit drew to a successful close. Leveraging the Greater Bay Area’s industrial, policy and professional capital strengths, it built a docking platform linking clinicians, researchers, enterprises and investors to advance deep medical-engineering integration and coordinated industry-university-research-medical development.

Moving forward, organizers will uphold the philosophy of Linkage, Integration, Commercialization, leveraging capital as a bond to connect universities, Grade A tertiary hospitals, enterprises and investment institutions, break barriers between lab prototypes and mass production, and deliver innovative technologies and industrial talents through full-chain professional services.

Cross-party coordination centered at the summit ultimately aims to accelerate access of high-performance medical devices to clinical settings to benefit patients, continuously drive upgrading of the Greater Bay Area life science industry, and support the Healthy China Initiative.